Nepal has banned the import of medicines of 16 Indian pharmaceutical companies. The Kathmandu government says that this has been done due to non-compliance with the rules set by the WHO.
According to a report by Nepal’s leading newspaper ‘Kathmandu Post’, the Government of Nepal’s Department of Medicine has issued a list of 16 Indian companies that were allegedly ignoring WHO regulations regarding the manufacture of medicines. . Nepal has decided not to import medicines manufactured by listed companies.
Santosh KCK, the spokesperson of Nepal Government’s Department of Medicines, said in this regard, “After inspecting the factories of these Indian pharmaceutical companies, which export their products to our country, we have published a list of these companies. which were not following the standard manufacturing procedures prescribed by the World Health Organization.”
WHO has set a standard code for the manufacture of medicines which aims to ensure that the medicine meets all the standards and criteria for the disease it is designed to treat. And the authorities are allowed to examine them.
Baba Ramdev’s company is also among the banned companies
Among the Indian companies that Nepal has banned from importing their products is yoga guru Baba Ramdev’s company Patanjali Ayurveda. Patanjali Ayurveda exports its medicines to Nepal under the name Divya Pharmacy.
Controversies have also been arising in India over certain medicines manufactured by Patanjali Ayurveda and the claims of Baba Ramdev, who is considered close to Prime Minister Narendra Modi, about these medicines.
The Medicines Department of the Government of Nepal sent a team of experts to India. who inspected the factories of pharmaceutical companies exporting their medicines to Nepal. The inspection was conducted between March 31 and July 22.
WHO warning regarding cough syrup
It should be noted that two months ago, the World Health Organization (WHO) issued a global alert regarding four cough syrups manufactured by Median Pharmaceuticals based in the Indian province of Haryana.
The alert was issued after several people suffered kidney failure and nearly 70 children died in Gambia. Most of these deaths were due to kidney failure after drinking the cough syrup. All these four syrups were manufactured and exported by Median Pharmaceuticals of Haryana. The Haryana state authorities had found several irregularities during the inspection of Median Pharma’s factories.
However, the drugs controller of India sent a letter to the WHO on December 13 saying that it would be premature to draw any conclusions regarding the link between the child deaths and the cough syrup. The Drug Controller of India further said that these cough syrups were tested in government laboratories and found to meet their standards.